loratadine / pseudoephedrine Extended Release Oral Tablet
RxNorm concept 668262, clinical dose form (scdf).
- RxCUI
- 668262
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/668262 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Extended Release Oral Tablet (DF, has dose form)
- pseudoephedrine (IN, has ingredient)
- loratadine (IN, has ingredient)
- loratadine / pseudoephedrine Extended Release Oral Tablet [Claritin-D] (SBDF, has tradename)
- loratadine / pseudoephedrine Extended Release Oral Tablet [Alavert D] (SBDF, has tradename)
- loratadine / pseudoephedrine Extended Release Oral Tablet [Wal-itin D] (SBDF, has tradename)
- loratadine / pseudoephedrine Extended Release Oral Tablet [Allerclear] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 668262 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/668262 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 668262. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.